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Background
MIF (macrophage migration inhibitory factor) is a proin-
flammatory cytokine regulator of host inflammatory and
immune responses, and is expressed by many different
cells types. Serum levels of MIF have been found to be
increased in several inflammatory diseases, Kawasaki dis-
ease (KD) included.
Objective
To evaluate possible differences in MIF polymorphisms
between patients with KD and healthy subjects, and
between KD patients with and without coronary altera-
tions. Methods. We screened for the MIF gene polymorf-
isms -173 a group of 69 patients discharged from our
hospital with a diagnosis of Kawasaki disease and 60
healthy controls.
Results
The average age at disease onset was 29 months (range, 3–
135 months). There were 43 females (33.3%) and 26
(20.2%) males. Eight children (12%) were non-respond-
ers to the first IVIG infusion. Nine children (13%) had
coronary alterations (ectasia or aneurysms). Statistical
analysis for MIF genotyping did not show significant dif-
ferences between patients and controls, both for allelic
and genotypic frequencies. However KD patients carrying
a MIF -173*C allele developed CAA more frequently than
those without these alleles (7/9 77.8% vs 16/44 26.7%, p
< 0.005) and the MIF -173*CC homozygosis resulted
more frequent in children with CAA than those without
(2/9 CC 22.2% vs 2/60 CC: 3.3%, p < 0.004). Moreover,
non-responders to a single IVIG infusion carried the MIF -
173*C allele more frequently than responders (6/8 = 75%
vs 17/61 = 28%, p < 0.014).
Conclusion
Our study suggest a potential relationship between a MIF
polymorphism and risk of CAA in KD.
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